Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study

M. Tempero, D. Y. Oh, J. Tabernero, M. Reni, E. Van Cutsem, A. Hendifar, D. T. Waldschmidt, N. Starling, J. B. Bachet, H. M. Chang, J. Maurel, R. Garcia-Carbonero, S. Lonardi, L. M. Coussens, L. Fong, L. C. Tsao, G. Cole, D. James, T. Macarulla

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Fingerprint

Dive into the research topics of 'Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study'. Together they form a unique fingerprint.

Medicine & Life Sciences